A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
Clinical trial NCT07298421 · RECRUITING
Trial details
- NCT number
- NCT07298421
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2030-05-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.